TCOM:CRYPTOCAPMarket Cap TCOM, $ Analysis
Data as of 2026-03-15 - not real-time
$51.72
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Trip.com Group (TCOM) is trading at $51.72, well below its 20‑day SMA of $53.25 and the 200‑day SMA of $65.95, indicating a bearish price trend. The RSI of 35.8 suggests the stock is approaching oversold territory, while the MACD line sits above its signal, offering a subtle bullish signal. Volatility remains high at 36% over the past 30 days, and beta around 0.80 points to moderate market sensitivity. Fundamentally, the company posted 21% YoY revenue growth in Q4 2025, maintains a robust gross margin of 80.6%, and trades at a low forward PE of 11.2 versus a trailing PE of 7.45, implying significant upside—analyst targets average $76, a ~47% upside from current levels. The dividend yield of 0.58% with a payout ratio under 5% appears sustainable. Recent earnings calls highlight strong top‑line momentum, yet emerging class‑action investigations introduce legal uncertainty.
Considering the undervalued valuation, solid cash position, and growth trajectory, the stock presents an attractive entry point for investors comfortable with sector cyclicality and moderate regulatory/geographic risks. A balanced approach that leverages the technical oversold signal while monitoring legal developments is advisable.
Considering the undervalued valuation, solid cash position, and growth trajectory, the stock presents an attractive entry point for investors comfortable with sector cyclicality and moderate regulatory/geographic risks. A balanced approach that leverages the technical oversold signal while monitoring legal developments is advisable.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI indicating oversold conditions
- Support level at $49.48 providing downside cushion
- Bullish MACD histogram suggesting short‑term momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 21% YoY revenue growth and strong margins
- Low PE and P/B ratios relative to industry peers
- Analyst price targets implying ~47% upside
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend with low payout ratio
- Long‑term travel demand recovery in China and abroad
- Potential regulatory and legal headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth20.80%
Profit Margin53.35%
P/E Ratio7.5
ROE21.13%
ROA3.87%
Debt/Equity18.16
P/B Ratio1.4
Technical Analysis
TrendBearish
RSI35.8
Support$49.48
Resistance$56.64
MA 20$53.25
MA 50$60.33
MA 200$65.95
MACDBullish
VolumeStable
Fear & Greed Index72.88
Valuation
Target Price$76.04
Upside/Downside47.02%
GradeUndervalued
TypeGrowth
Dividend Yield0.58%
Risk Assessment
Beta0.80
Volatility36.24%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.